Breaking News Instant updates and real-time market news.

DE

Deere

$163.47

-1.78 (-1.08%)

, ED

Consolidated Edison

$77.26

-1.34 (-1.70%)

10:18
02/13/19
02/13
10:18
02/13/19
10:18

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Neutral from Buy at BofA/Merrill with analyst Ross Gilardi saying he views risk/reward as more balanced heading into Friday's Q1 report following recent share outperformance. 2. Consolidated Edison (ED) downgraded to Underperform from In Line at Evercore ISI. 3. Clearway Energy (CWEN) downgraded to Sell from Neutral at Guggenheim with analyst Shahriar Pourreza saying he expects the company to announce a dividend cut in the next few days after his discussions with key stakeholders and the management, adding that "at a minimum," the company's cash may be "locked up at the project level for a pronounced period of time." 4. Huntsman (HUN) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas saying the company has its work cut out to reach its own adjusted EBITDA forecasts for 2019. 5. Aquantia (AQ) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

DE

Deere

$163.47

-1.78 (-1.08%)

ED

Consolidated Edison

$77.26

-1.34 (-1.70%)

CWEN

Clearway Energy

$14.17

-0.5 (-3.41%)

HUN

Huntsman

$22.85

-0.15 (-0.65%)

AQ

Aquantia

$7.32

-2.58 (-26.06%)

  • 14

    Feb

  • 15

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

  • 25

    Mar

  • 26

    Mar

DE Deere
$163.47

-1.78 (-1.08%)

01/09/19
ARGS
01/09/19
NO CHANGE
Target $170
ARGS
Buy
Deere price target raised to $170 from $166 at Argus
Argus analyst John Eade kept his Buy rating on Deere and raised his price target to $170 after its management raised its mid-cycle operating margin target to 15% from 12% in a meeting with sell-side analysts yesterday. The analyst notes that while the stock has been impacted by the trade tensions, he expects Deere to generate "continued earnings power in the quarters ahead".
01/18/19
OTRG
01/18/19
UPGRADE
OTRG
Positive
Deere upgraded to Positive from Mixed at OTR Global
OTR Global upgraded Farm Equipment Manufacturers, Agco (AGCO), CNH Industrial (CNHI), and Deere (DE), to Positive from Mixed. The firm's checks indicate strong late-season harvests, tariff-related subsidies and small OEM incentives resulted in U.S. farmers increasing year-end purchases, boosting dealers' orders and sales outlooks.
02/13/19
BOFA
02/13/19
DOWNGRADE
BOFA
Neutral
Deere downgraded to Neutral from Buy at BofA/Merrill
02/13/19
02/13/19
DOWNGRADE
Target $170

Neutral
Deere downgraded to Neutral on valuaiton at BofA/Merrill
As previously reported, BofA/Merrill downgraded Deere to Neutral from Buy with a $170 price target. Analyst Ross Gilardi views risk/reward as more balanced heading into Friday's Q1 report following recent share outperformance.
ED Consolidated Edison
$77.26

-1.34 (-1.70%)

11/05/18
GSCO
11/05/18
UPGRADE
GSCO
Neutral
Consolidated Edison upgraded to Neutral from Sell at Goldman Sachs
11/06/18
GSCO
11/06/18
UPGRADE
Target $73
GSCO
Neutral
Consolidated Edison upgraded to Neutral with $73 target at Goldman Sachs
Goldman Sachs analyst Michael Lapides last night upgraded Consolidated Edison to Neutral from Sell and raised his price target for the shares to $73 from $72. The analyst is more positive on the shares following the underperformance in 2018. Further, to reflect improved regulated earnings and renewable growth in 2019, Lapides slightly increased his long-term estimates for Consolidated Edison.
01/18/19
BOFA
01/18/19
DOWNGRADE
BOFA
Neutral
Consolidated Edison downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith downgraded Consolidated Edison (ED) to Neutral and trimmed his price target to $80 from $83 citing a series of cautious datapoints. The analyst cites exposure to PG&E (PCG), pipeline permitting headlines that are cautious including risks to its MVP project, and potential further negative earnings revisions.
02/12/19
EVER
02/12/19
DOWNGRADE
EVER
Underperform
Consolidated Edison downgraded to Underperform from In Line at Evercore ISI
CWEN Clearway Energy
$14.17

-0.5 (-3.41%)

01/07/19
GUGG
01/07/19
DOWNGRADE
GUGG
Neutral
Clearway Energy downgraded to Neutral from Buy at Guggenheim
01/07/19
GUGG
01/07/19
DOWNGRADE
GUGG
Neutral
Clearway Energy downgraded to Neutral at Guggenheim
As previously reported, Guggenheim downgraded Clearway Energy to Neutral from Buy and cut its price target to $17 from $22. Analyst Shahriar Pourreza expects Clearway shares to work but said it will take time as more comfort is gained with the sponsor, contract quality, and pipeline opportunities.
02/13/19
GUGG
02/13/19
DOWNGRADE
GUGG
Sell
Clearway Energy downgraded to Sell from Neutral at Guggenheim
02/13/19
02/13/19
DOWNGRADE
Target $11

Sell
Clearway Energy downgraded to Sell at Guggenheim on likely dividend cut
As previously reported, Guggenheim analyst Shahriar Pourreza downgraded Clearway Energy to Sell from Neutral and lowered his price target to $11 from $17. The analyst expects the company to announce a dividend cut in the next few days after his discussions with key stakeholders and the management, adding that "at a minimum", the company's cash may be "locked up at the project level for a pronounced period of time". Pourreza also lowers his forecast for Clearway Energy 2019 EBITDA to $818.6M from $1.07B.
HUN Huntsman
$22.85

-0.15 (-0.65%)

02/13/19
JPMS
02/13/19
DOWNGRADE
Target $24
JPMS
Neutral
JPMorgan downgrades Huntsman to Neutral with $24 price target
JPMorgan analyst Jeffrey Zekauskas downgraded Huntsman (HUN) to Neutral from Overweight and lowered his price target for the shares to $24 from $25. The company has its work cut out to reach its own adjusted EBITDA forecasts for 2019, Zekauskas tells investors in a research note. Further, the analyst believes "other higher-quality intermediate chemical companies," such as Eastman Chemical (EMN), have higher free cash flow generation per share and less risk to their 2019 earnings profile.
02/13/19
JPMS
02/13/19
DOWNGRADE
Target $24
JPMS
Neutral
Huntsman downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Huntsman to Neutral and lowered his price target for the shares to $24 from $25.
11/02/18
SBSH
11/02/18
NO CHANGE
SBSH
Neutral
Citi closes negative catalyst watch on Huntsman
Citi analyst P.J. Juvekar closed his negative catalyst watch on Huntsman following the recent pullback in the shares. He keeps a Neutral rating on the name.
10/31/18
KEYB
10/31/18
NO CHANGE
Target $36
KEYB
Overweight
Huntsman price target lowered to $36 from $42 at KeyBanc
KeyBanc analyst Michael Sison lowered his price target for Huntsman to $36 from $42, while reiterating an Overweight rating on the shares as he believes the company is better positioned to post steady results when commodity MDI comes off its peak. The analyst continues to see solid volume growth in differentiated MDI and recovery in Performance Products.
AQ Aquantia
$7.32

-2.58 (-26.06%)

02/13/19
NORL
02/13/19
NO CHANGE
Target $9.5
NORL
Outperform
Aquantia technology valuable to a strategic buyer, says Northland
Northland analyst Gus Richard lowered his price target on Aquantia to $9.50 from $10.00 after the company reported results and guidance that he said "were atrocious," continuing a trend of several misses since going public. While he acknowledges the stock will "be punished today," Richard keeps an Outperform rating on Aquantia shares as he believes that the company's technology is valuable to a strategic buyer who can create operational efficiencies.
02/13/19
02/13/19
DOWNGRADE

Market Perform
Aquantia downgraded to Market Perform from Outperform at Raymond James
As previously reported, Raymond James analyst Chris Caso downgraded Aquantia (AQ) to Market Perform after its Q4 earnings miss and a "significant" cut to its 2019 expectations. The analyst notes that he is typically reluctant to make rating changes after earnings, but sees the latest reported quarter as "thesis changing", citing the most serious weakness coming from the company's largest customer - Intel (INTC). Caso adds that Aquantia's revenue is expected to fall "sharply due to a combination of excess inventory" and a market opportunity that is "much lower than expected."
02/13/19
MSCO
02/13/19
DOWNGRADE
Target $9
MSCO
Equal Weight
Aquantia downgraded to Equal Weight on Intel weakness at Morgan Stanley
As previously reported, Morgan Stanley analyst Joseph Moore downgraded Aquantia (AQ) to Equal Weight from Overweight, stating that the company's large shortfall in its enterprise business in Q4 and guidance for a severe correction in its data center business throughout next year is "a thesis changer." While he still thinks that the company has a strong position, Moore said strong growth in the PC and settop box business and solid growth in enterprise will not be enough to offset the Intel (INTC) weakness. The analyst, who also thinks the company's lack of visibility into trends at Intel has been surprising, cut his price target on Aquantia shares to $9.00 from $12.50.
02/13/19
MSCO
02/13/19
DOWNGRADE
MSCO
Equal Weight
Aquantia downgraded to Equal Weight from Overweight at Morgan Stanley

TODAY'S FREE FLY STORIES

ATVI

Activision Blizzard

$41.62

-0.28 (-0.67%)

, TTWO

Take-Two

$86.50

-1.08 (-1.23%)

12:37
02/22/19
02/22
12:37
02/22/19
12:37
Periodicals
FTC plans public workshop to go over loot boxes in video games, Verge reports »

The Federal Trade…

ATVI

Activision Blizzard

$41.62

-0.28 (-0.67%)

TTWO

Take-Two

$86.50

-1.08 (-1.23%)

EA

Electronic Arts

$94.44

-2.39 (-2.47%)

UBSFY

Ubisoft

$0.00

(0.00%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 12

    Mar

  • 13

    Mar

  • 21

    Mar

KPTI

Karyopharm

$9.03

0.07 (0.78%)

12:35
02/22/19
02/22
12:35
02/22/19
12:35
Hot Stocks
Karyopharm quickly drops 16.5% »

Shares of Karyopharm have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

KPTI

Karyopharm

$9.04

0.08 (0.89%)

12:32
02/22/19
02/22
12:32
02/22/19
12:32
Hot Stocks
Breaking Hot Stocks news story on Karyopharm »

Karyopharm trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

BIDU

Baidu

$166.90

-4.82 (-2.81%)

12:30
02/22/19
02/22
12:30
02/22/19
12:30
Options
10.1K Baidu Mar 170 - Sep 165 put spreads trade $7.20 after earnings »

10.1K Baidu Mar 170 - Sep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

UBS

UBS

$12.38

0.055 (0.45%)

12:30
02/22/19
02/22
12:30
02/22/19
12:30
Periodicals
UBS ignored warnings in French tax case for years, Reuters says »

According to a written…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
02/22/19
02/22
12:30
02/22/19
12:30
General news
FX Action: USD-JPY »

FX Action: USD-JPY traded…

12:25
02/22/19
02/22
12:25
02/22/19
12:25
General news
Fed VC Clarida said the Fed should be "open minded" »

Fed VC Clarida said the…

GM

General Motors

$39.67

0.04 (0.10%)

12:23
02/22/19
02/22
12:23
02/22/19
12:23
Hot Stocks
GM says over 1,500 employees volunteered to transfer to other U.S. locations »

General Motors said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

GM

General Motors

$39.66

0.03 (0.08%)

12:21
02/22/19
02/22
12:21
02/22/19
12:21
Hot Stocks
GM extends production at Detroit/Hamtramck into January 2020 »

GM said it has notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NWSA

News Corp.

$13.04

0.25 (1.95%)

12:20
02/22/19
02/22
12:20
02/22/19
12:20
Options
Notable print in News Corp puts »

Notable print in News…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
02/22/19
02/22
12:17
02/22/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
02/22/19
02/22
12:16
02/22/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$50.60

0.14 (0.28%)

, FOXA

21st Century Fox

$50.89

0.15 (0.30%)

12:14
02/22/19
02/22
12:14
02/22/19
12:14
Periodicals
Fox removes Jussie Smollett from last two episodes of 'Empire' season, WSJ says »

Producer's of Fox…

FOX

21st Century Fox

$50.60

0.14 (0.28%)

FOXA

21st Century Fox

$50.89

0.15 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

12:13
02/22/19
02/22
12:13
02/22/19
12:13
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened with modest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$7.70

-0.26 (-3.27%)

12:05
02/22/19
02/22
12:05
02/22/19
12:05
Periodicals
JAMA editorial says DBV trial results 'not easy to interpret' »

In an editorial published…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$11.15

0.12 (1.09%)

12:05
02/22/19
02/22
12:05
02/22/19
12:05
Options
GameStop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTN

Union Acquisition Corp

$5.89

-1.44 (-19.65%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Union Acquisition Corp falls -17.3% »

Union Acquisition Corp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

TDS

Telephone and Data

$32.14

-4.55 (-12.40%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Telephone and Data falls -12.5% »

Telephone and Data is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

DPLO

Diplomat Pharmacy

$7.65

-5.81 (-43.16%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Diplomat Pharmacy falls -42.9% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

PBI

Pitney Bowes

$8.25

1.225 (17.45%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Pitney Bowes rises 17.4% »

Pitney Bowes is up 17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    Mar

SWM

Schweitzer-Mauduit

$41.20

6.51 (18.77%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Schweitzer-Mauduit rises 19.0% »

Schweitzer-Mauduit is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 28

    Mar

W

Wayfair

$153.23

36.09 (30.81%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Wayfair rises 30.9% »

Wayfair is up 30.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

CAG

Conagra Brands

$23.13

-0.95 (-3.95%)

11:55
02/22/19
02/22
11:55
02/22/19
11:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
02/22/19
02/22
11:55
02/22/19
11:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

11:55
02/22/19
02/22
11:55
02/22/19
11:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.